GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NextGen Healthcare Inc (NAS:NXGN) » Definitions » GF Value

NextGen Healthcare (NextGen Healthcare) GF Value : $21.48 (As of May. 15, 2024)


View and export this data going back to 1982. Start your Free Trial

What is NextGen Healthcare GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

  1. Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
  2. GuruFocus adjustment factor based on the company’s past returns and growth.
  3. Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-15), NextGen Healthcare's share price is $23.94. NextGen Healthcare's GF Value is $21.48. Therefore, NextGen Healthcare's Price-to-GF-Value for today is 1.11.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes NextGen Healthcare is Data Out of Date, Use Caution.


NextGen Healthcare  (NAS:NXGN) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)Predictable Companies that possibly be Value Traps
Significantly OvervaluedPredictable Companies which are Significantly Overvalued
Modestly OvervaluedPredictable Companies which are Modestly Overvalued
Fairly ValuedPredictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

NextGen Healthcare's Price-to-GF-Value for today is calculated as

Price-to-GF-Value=Share Price/GF Value
=23.94/21.48
=1.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NextGen Healthcare GF Value Related Terms

Thank you for viewing the detailed overview of NextGen Healthcare's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.


NextGen Healthcare (NextGen Healthcare) Business Description

Traded in Other Exchanges
N/A
Address
3525 Piedmont Road, NE Building 6, Suite 700, Atlanta, GA, USA, 30305
NextGen Healthcare Inc is a United States-based company that provides healthcare solutions. The company offers technology and services platform supports for ambulatory and specialty practices of all sizes. It provides software, services, and analytics solutions to medical and dental group practices.
Executives
Three Prong Investments, Llc 10 percent owner 1695 VIKING RD, LAGUNA BEACH CA 92651
David A Metcalfe officer: Chief Technology Officer 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Mitchell Waters officer: EVP, Commercial Growth 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Craig A. Barbarosh director 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
David Ahmadzai officer: Chief Accounting Officer 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Donna Cullen Greene officer: EVP, Human Resources 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Srinivas S Velamoor officer: EVP, Business Development 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
David William Sides officer: President and CEO 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Arnold James Robert Jr. officer: Chief Financial Officer 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Darnell Dent director 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Pamela Puryear director 253 DOLPHIN COVE QUAY, STAMFORD CT 06902
Geraldine Mcginty director 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Lonnie Allen Plunk officer: EVP, Operations 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
John R Frantz officer: CEO and President 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305
Lance Rosenzweig director 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305